For help on how to get the results you want, see our search tips.
320 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Additional monitoring Remove Additional monitoring filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Libtayo (updated)
Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019,
, 
, Revision: 2, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
lenvatinib mesylate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, 
, Revision: 12, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, 
, Revision: 8, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Lemtrada (updated)
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,
, , Revision: 10, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Exjade (updated)
deferasirox, beta-Thalassemia, Iron Overload
Date of authorisation: 28/08/2006,, Revision: 45, Authorised, Last updated: 20/07/2020
-
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, 
, Revision: 4, Authorised, Last updated: 16/07/2020
-
List item
Human medicine European public assessment report (EPAR): Ultomiris (updated)
ravulizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 02/07/2019,, Revision: 3, Authorised, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Vihuma (updated)
simoctocog alfa, Hemophilia A
Date of authorisation: 13/02/2017,, Revision: 3, Authorised, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Delstrigo (updated)
doravirine, lamivudine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 22/11/2018,, Revision: 5, Authorised, Last updated: 14/07/2020
-
List item
Human medicine European public assessment report (EPAR): Talzenna (updated)
talazoparib, Breast Neoplasms
Date of authorisation: 20/06/2019,, Revision: 2, Authorised, Last updated: 14/07/2020
-
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
cabozantinib s-malate, Carcinoma, Renal Cell
Date of authorisation: 09/09/2016,, , Revision: 8, Authorised, Last updated: 14/07/2020
-
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017,, Revision: 9, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Mektovi (updated)
binimetinib, Melanoma
Date of authorisation: 20/09/2018,, Revision: 3, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Glivec (updated)
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001,, Revision: 38, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Juluca (updated)
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,, Revision: 3, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Darzalex (updated)
Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016,, , , Revision: 12, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trazimera (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, , Revision: 6, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trogarzo (updated)
Ibalizumab, HIV Infections
Date of authorisation: 26/09/2019,, Revision: 2, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Elocta (updated)
efmoroctocog alfa, Hemophilia A
Date of authorisation: 18/11/2015,, Revision: 9, Authorised, Last updated: 08/07/2020
-
List item
Human medicine European public assessment report (EPAR): Ondexxya (updated)
andexanet alfa, Drug-Related Side Effects and Adverse Reactions
Date of authorisation: 26/04/2019,, , Revision: 4, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): Taltz (updated)
ixekizumab, Psoriasis
Date of authorisation: 25/04/2016,, Revision: 10, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): Tavlesse
Fostamatinib disodium, Thrombocytopenia
Date of authorisation: 09/01/2020,, Revision: 2, Authorised, Last updated: 06/07/2020
-
List item
Human medicine European public assessment report (EPAR): Intuniv
guanfacine hydrochloride, Attention Deficit Disorder with Hyperactivity
Date of authorisation: 17/09/2015,, Revision: 7, Authorised, Last updated: 06/07/2020
-
List item
Human medicine European public assessment report (EPAR): Biktarvy
bictegravir, emtricitabine, tenofovir alafenamide, fumarate, HIV Infections
Date of authorisation: 21/06/2018,, Revision: 6, Authorised, Last updated: 03/07/2020
-
List item
Human medicine European public assessment report (EPAR): Synjardy
empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015,, Revision: 16, Authorised, Last updated: 03/07/2020